In this context, a prospective study [80] analyzed 46 targeted biopsies of both suspicious and non-suspicious areas on mpMRI and Ga-PSMA-PET/CT in 5 high-risk PCa patients. The gene discussed is FOLH1; the disease is posterior cortical atrophy.